We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
24.50 | 1.40% | 1,780.50 | 1,780.00 | 1,781.00 | 1,784.00 | 1,740.50 | 1,743.50 | 2,033,215 | 15:56:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.61 | 71.99B |
Date | Subject | Author | Discuss |
---|---|---|---|
02/11/2023 14:58 | Ftse having been up today will lose its steam tomorrow which means GSK will most likely fall again . | abdullla | |
02/11/2023 14:43 | I'm not putting any more money in here. Best option it to trade the range i suppose.I will wait until it is 1500 and sell some | supermarky | |
02/11/2023 14:29 | Market in unforgiving mode. Astra received similar a while back. Would anyone be tempted? Would it receive approval? Ms W, I think, should be looking for a successor if this pattern carries on for much longer. | patientcapital | |
02/11/2023 14:09 | perhaps if they post terrible results the share price will go through the roof. ftse up over 100 points and this is obviously being kicked about. | supermarky | |
02/11/2023 13:46 | #Monty, I have a few of those and look at the FTSE portfolio as an annuity, what it cranks out in dividends is what matters, take them to live on or roll them all back in again and grow the PF for free.. :o) | laurence llewelyn binliner | |
02/11/2023 13:44 | Next we are back down!!! | mj19 | |
02/11/2023 13:40 | One minute the vaccines business going forward is biggest growth area. And the stock is undervalued | mj19 | |
02/11/2023 10:54 | Sorry boys made a mistake I said shareprice below what it was 30 years ago, it's 37 years ago, I just treat this as a bond with a low yield, compared to what you can get. | montyhedge | |
02/11/2023 10:19 | Seems to be GSK specific??? Very strange as only news today is good news - It is still very early days, but GSK’s respiratory syncytial virus (RSV) Arexvy seems to have flown out of the traps more quickly than Pfizer’s rival shot Abrysvo in the first weeks since they reached the market. | alphorn | |
02/11/2023 10:19 | Terrible is the only word for this | mj19 | |
02/11/2023 10:17 | right in the wallet.. | lippy4 | |
02/11/2023 10:02 | This is very painful | panache1 | |
02/11/2023 09:40 | Almost 1500 around 24hrs ago and now sub 1400!! Having got back in recently at 1430ish I will add slowly but was thinking about taking a quick profit at the open yesterday!! Good luck all 👍🏻 | tuftymatt | |
02/11/2023 09:37 | JP Morgan reiterate its Sell rating. The target price is increased from GBX 1300 to GBX 1400. | hjs | |
02/11/2023 09:24 | Will be on a single digit multiple soon | spoole5 | |
02/11/2023 09:23 | has this share got covid??? | lippy4 | |
02/11/2023 09:22 | .... and a 'buy' reccomendation in today's Tempus column, albeit a rather lukewarm one. | zho | |
02/11/2023 09:13 | Oh dear, yes and it flies in the face of an outstanding set of Q3 results.... :0( | tradermichael | |
02/11/2023 09:07 | Wow what a drop it continues | mj19 | |
02/11/2023 08:40 | A bond issued by a third world country?! | spoole5 | |
02/11/2023 08:15 | I treat GSK as a bond, shareprice way below what it was when they took over Smith Kline Beecham, but use to get 6% dividend so ok we put up with management.So no growth in shareprice for 30 years absolutely awful. I can't see things changing. | montyhedge | |
01/11/2023 21:37 | It's simple maths here.....divi of c 4% and sfa about it in today's update is a downer in a market where you can get 5-6% safe treasuries/money market funds. Emma needs to get her priorities right-otherwise this could drift to £12 to make the yield competitive, and the market needs to see sustained growth before trusting GSK again | cumnor | |
01/11/2023 15:46 | Whats happened in the past is no presdent what might happen over the next 20 years... | igoe104 | |
01/11/2023 15:38 | You can't have this share for capital growth, shareprice below what it was 30 years ago, no growth, but for income good payer. | montyhedge | |
01/11/2023 14:37 | Days range is over a pound lol. This flipping share.. | rikky72 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions